11-22193331-A-AAGGAGGAGGGGAATGAGGAGGAGG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_213599.3(ANO5):c.-156_-155insAGGGGAATGAGGAGGAGGAGGAGG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.82 ( 50911 hom., cov: 0)
Exomes 𝑓: 0.79 ( 394924 hom. )
Failed GnomAD Quality Control
Consequence
ANO5
NM_213599.3 5_prime_UTR
NM_213599.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -2.16
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-22193331-A-AAGGAGGAGGGGAATGAGGAGGAGG is Benign according to our data. Variant chr11-22193331-A-AAGGAGGAGGGGAATGAGGAGGAGG is described in ClinVar as [Benign]. Clinvar id is 304093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANO5 | NM_213599.3 | c.-156_-155insAGGGGAATGAGGAGGAGGAGGAGG | 5_prime_UTR_variant | 1/22 | ENST00000324559.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANO5 | ENST00000324559.9 | c.-156_-155insAGGGGAATGAGGAGGAGGAGGAGG | 5_prime_UTR_variant | 1/22 | 1 | NM_213599.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.819 AC: 123203AN: 150488Hom.: 50858 Cov.: 0
GnomAD3 genomes
AF:
AC:
123203
AN:
150488
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.787 AC: 999937AN: 1270584Hom.: 394924 Cov.: 57 AF XY: 0.786 AC XY: 484315AN XY: 616144
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
999937
AN:
1270584
Hom.:
Cov.:
57
AF XY:
AC XY:
484315
AN XY:
616144
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.819 AC: 123317AN: 150606Hom.: 50911 Cov.: 0 AF XY: 0.816 AC XY: 59991AN XY: 73484
GnomAD4 genome
AF:
AC:
123317
AN:
150606
Hom.:
Cov.:
0
AF XY:
AC XY:
59991
AN XY:
73484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Limb-girdle muscular dystrophy, recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Gnathodiaphyseal dysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Miyoshi myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at